{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NeOnc Technologies Holdings, Inc."},"Symbol":{"label":"Symbol","value":"NTHI"},"Address":{"label":"Address","value":"2 DOLE DRIVE,,WESTLAKE VILLAGE,,0.0,0.0,0.0, CA, 91362, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Our company (NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer."},"CompanyUrl":{"label":"Company Url","value":"https://neonc.com/"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}